Are GLP-1s Increasing Eating Disorder Risk?

Published Date: 19 Jun 2026

With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.

Read Full News

Latest News

Diet Program May Not Match Knee Surgery in Knee OA & Obesity

In patients with obesity and knee osteoarthritis eligible for knee arthroplasty, an intensive dietary weight-loss program is clinically inferior to surgery for patient-reported pain and function.

Increasing GLP-1 Use Raises Muscle Loss Concerns

Incretin mimetic therapy for obesity may reduce muscle mass and bone mineral density, but its effects on physical function and the risk for fractures in older adults remain uncertain.

Spermidine Intake Tied to Liver Health in Obesity and MetS

An increase in dietary spermidine intake over 1 year is associated with improvements in hepatic function and cardiometabolic health in older adults with overweight or obesity and metabolic syndrome.

USG Detects Vagus Nerve Atrophy in Parkinson's Disease

Ultrasound imaging reveals structural changes in the vagus nerve of patients with Parkinson's disease in a meta-analysis.

SGLT2-GLP-1 Combo Little Better Than Monotherapy in T2D

Using both SGLT2 inhibitors and GLP-1 receptor agonists is no more effective than using either drug alone in patients with type 2 diabetes, a new meta-analysis suggests.

Mindfulness-Based Eating Improves Anxiety, Eating Behavior

A mindfulness-based eating intervention improved anxiety, depression, and eating behaviors in adults with obesity and generalized anxiety disorder.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Latest News

In patients with obesity and knee osteoarthritis eligible for knee arthroplasty, an intensive dietary weight-loss program is clinically inferior to surgery for patient-reported pain and function.

Incretin mimetic therapy for obesity may reduce muscle mass and bone mineral density, but its effects on physical function and the risk for fractures in older adults remain uncertain.

An increase in dietary spermidine intake over 1 year is associated with improvements in hepatic function and cardiometabolic health in older adults with overweight or obesity and metabolic syndrome.

Ultrasound imaging reveals structural changes in the vagus nerve of patients with Parkinson's disease in a meta-analysis.

Using both SGLT2 inhibitors and GLP-1 receptor agonists is no more effective than using either drug alone in patients with type 2 diabetes, a new meta-analysis suggests.

A mindfulness-based eating intervention improved anxiety, depression, and eating behaviors in adults with obesity and generalized anxiety disorder.

News All Time

Glucose, A1c Mediate Obesity-Pancreatic Cancer Link

Higher BMI, waist size, and waist-hip ratio are linked to an increased risk for pancreatic cancer, and part of the association is explained by poor glycaemic control, a study finds.

Alcohol and Marijuana Use in Type 1 Diabetes: What to Know

People with type 1 diabetes are just as likely to use substances as the rest of the population, so they need to be aware of the risks and how to mitigate them.

Semaglutide Tied to Lower Risk for Adult-Onset Seizure

In adults with type 2 diabetes, semaglutide initiation was associated with roughly half the risk for adult-onset seizure compared with other glucose-lowering medications — a protective effect that appeared independent of blood sugar or weight control.

Once-Daily Prednisolone Shows Promise for Hypoadrenalism

In a small study, once-daily prednisolone outperformed hydrocortisone for bone and cardiometabolic outcomes in patients with adrenal insufficiency.

Kidney Disease Hits Early, Hard in Kids With Spina Bifida

A population-based study finds that children with spina bifida are more likely than their peers in the general population to develop chronic kidney disease and ESRD — and to do so at younger ages.

India Approves Novo Nordisk's Obesity Drug Wegovy for Fatty Liver Disease

Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its ⁠obesity drug Wegovy for the treatment of metabolic dysfunction-associated...

Visceral Belly Fat Can Make You Age Faster, Experts Warn

Higher visceral fat is linked to accelerated biological aging in middle-aged adults, independent of other adiposity measures and lifestyle factors.

Glucocorticoid Use in Giant Cell Arteritis Remains High

Despite efforts to reduce glucocorticoid exposure in GCA, patients diagnosed in 2022 still received high doses — and even low-dose exposure was associated with adverse outcomes.

Does High Cortisol Shut Down GLP-1s?

Claims circulating on social media warn that high cortisol levels can block the weight-loss effects of GLP-1, but obesity medicine experts say there is no evidence to support the idea.

Managing Diabetes and HIV Together: What to Know

As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, requiring specialized management approaches.

GLP-1s May Reduce Overdose Risk, Even After Discontinuation

People with a history of alcohol, opioid, or substance overdose who are later started on GLP-1 medications have a significantly lower risk for a repeat overdose.

South Africa's IDexis Appeals Court Ruling Over Compounded Weight-loss Drugs

South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production ⁠of compounded weight-loss medicines, disputing...

Study Flags Need to Monitor Frailty Risks With GLP-1 Drugs for Older Adults

Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study...

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated ⁠by injections, which could potentially broaden the use...

Do Infant Food Portion Sizes Matter for Later Overweight?

Larger food portions during complementary feeding are associated with higher odds of overweight in both early and later childhood.

Semaglutide Linked to Rare Brain Illness

In rare cases, semaglutide for obesity is linked to Wernicke encephalopathy, driven by gastrointestinal intolerance, reduced nutritional intake, and rapid weight loss leading to thiamine deficiency.

Recommended News For You

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

Using MRD Status to Deescalate Multiple Myeloma Therapy

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Scientists develop scans that light up aggressive cancer tumors for better treatment

FDA Approves Sickle Cell Gene Therapy for Young Kids

Prostate Cancer Treatment Associated With Long-Term Complications

Recommended Articles For You

Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology 

An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients 

Clinical Perspectives in Oncology for Better Care 

Strategic Practices in Oncology for Specialists 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mental health risk persists years after cancer diagnosis

2.

Breast cancer prevention: How nurse practitioners and physician assistants can help

3.

For treatment, the majority of cancer patients choose complementary therapies.

4.

Cancer mortality continuing to decline, says report

5.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

1.

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success

2.

Bone Marrow Microenvironment Biomarkers in Hematologic Health

3.

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells

4.

HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer

5.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot